Type 1 Diabetes
Type 1 diabetes (T1D) is a life-altering, incurable disease which is one of the most challenging to treat and often results in complications and a shortened life expectancy. Roughly 2 million patients are currently living with T1D in the United States and the number of annual diagnoses is on the rise. It usually strikes children and young adults.
T1D is an autoimmune disease in which a person’s own body attacks its insulin-producing cells in the pancreas. These cells are required to break down glucose. Without them, the body cannot break down glucose—elevated glucose kills cells and results in complications and ultimately death if not controlled. T1D is managed today by a rigorous regimen of testing glucose levels and injecting insulin between 3-5 times per day or by wearing an insulin pump.
The Leona M. and Harry B. Helmsley Charitable Trust supports innovative and collaborative funding for T1D.